International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2020 - Volume 24, Number 2
View All Articles in Issue

Page(s): 131

Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: cholecalciferol, formulation, stability, storage temperature, vitamin D deficiency, rickets, familial hypophosphatemia, hypoparathyroidism, Fanconi syndrome, dietary supplement, nutritional supplementation, calcium uptake

Related Categories: EXCIPIENTS, FORMULATIONS, NUTRITION AND NUTRICEUTICALS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 131
Cholecalciferol 40,000-IU/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 243
Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 489
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 55
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Riepl Mike	May/Jun 2019 Pg. 192-199
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations Newton David W	Jul/Aug 2019 Pg. 281-287
Topiramate 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 138
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Geiger Christine M, Sorenson Bridget, Whaley Paul	Sep/Oct 2015 Pg. 420-427
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 149
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 133
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2020 Pg. 134
Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 135
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 136
Terbinafine 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 137
Acetazolamide 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 130
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Voudrie Mark A II, Allen D Brett	Jan/Feb 2010 Pg. 82-85
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Geiger Christine M, Sorenson Bridget, Whaley Paul A	Jul/Aug 2013 Pg. 344-346
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2021 Pg. 145
Vitamin A Suppository Allen Loyd V Jr	Jul/Aug 2008 Pg. 363
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2019 Pg. 234
Return to Top